SABiosciences

Frederick, United States Founded: 1998 • Age: 28 yrs Acquired By Qiagen
Pathway-focused real-time PCR assay panels are developed and commercialized.

About SABiosciences

SABiosciences is a company based in Frederick (United States) founded in 1998 by Li Shen was acquired by Qiagen in November 2009. SABiosciences offers products and services including QIAcuityDx, QIAwave Kits, Proteinase K, and TissueLyser III. SABiosciences operates in a competitive market with competitors including Abcam, Stem Cell Technologies, GenScript, Sino Biological and Miltenyi Biotec, among others.

Key Metrics

Products & Services of SABiosciences

SABiosciences offers a comprehensive portfolio of products and services, including QIAcuityDx, QIAwave Kits, Proteinase K, and TissueLyser III.

QIAcuityDx
Digital PCR System

Automated tool for precise detection and quantification of genetic variations.

QIAwave Kits
Nucleic Acid Extraction

Eco-friendly kits for sustainable extraction of DNA and RNA samples.

Proteinase K
Enzymes

Efficient enzyme for protein digestion in biological sample preparation.

TissueLyser III
Sample Preparation

Instrument for effective lysis of challenging samples for analysis.

Investors in SABiosciences

SABiosciences has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Qiagen.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Products and reagents for molecular diagnostic assays are supplied.
1984qiagen.comHilden, Germany
Premium access

Investor details for SABiosciences

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of SABiosciences

2 people are tracked at SABiosciences (2 in leadership).

NameRoleGroup
Li Shen
Co-FounderLeadership
Peer Schatz
CEOLeadership
Premium access

Complete people profiles for SABiosciences

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of SABiosciences

2 dated milestones of SABiosciences across 11 years, from founding to its latest funding, stage changes and deals.

  1. Founded SABiosciences is founded.
  2. Exit Acquired by Qiagen.

Competitors of SABiosciences

SABiosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Abcam, Stem Cell Technologies, GenScript, Sino Biological and Miltenyi Biotec, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
abcam.com1998Cambridge, United Kingdom$78.8M405
Biological reagents and antibodies are developed for life science research.
stemcell.com1993Vancouver, Canada$11.92M129
Developer of cell culture media and ancillary reagents for life science research
genscript.com2002Piscataway, United States$15M5,260
Reagents and instruments are provided for life sciences research.
sinobiological.com2007Beijing, China$29.41M–
Reagents and kits are provided for clinical research applications.
miltenyibiotec.com1989Bergisch Gladbach, Germany–585
Develops tools and products for research and clinical application
devyser.com2004Stockholm, Sweden$15.48M–
Provider of molecular diagnostic kits for cancer, hereditary diseases, and reproductive disorders
exonhit.com1997Paris, France$65.46M–
Fully integrated in vitro diagnostics company specializing in transplantation, infectious diseases and cancer diagnosis
origene.com1996Rockville, United States$69.55M141
Proteins, antibodies, and molecular tools are manufactured for research applications.
sangon.com2003Shanghai, China$300M–
Research services, reagents, and kits for biotech applications are provided.
meridianbioscience.com1976Ohio, United States––
Molecular diagnostic device and kits
Premium access

Detailed competitors of SABiosciences

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of SABiosciences

Websites that share an audience with SABiosciences (sabiosciences.com).

Similar websites

Websites whose visitors overlap most with SABiosciences. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
qiagen.com
100%
458.2K#105,023View details
rndsystems.com
96%
349K#159,292View details
promega.com
promega.com
86%
–#192,389–
systembio.com
85%
23.8K#1,129,361View details
jacksonimmuno.com
71%
–#680,486View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 18 similar websites and full traffic analytics for SABiosciences

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 18 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Similar companies to SABiosciences

10 companies that operate in the same segment as SABiosciences (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
mRNA-based therapeutics for diseases including cancer and infections are developed.
2010Cambridge, Massachusetts, United StatesUSD 2.78 BUSD 1.94 B5,800
Digital sequencing technology for cancer detection is developed.
2012Redwood City, California, United StatesUSD 557.5 MUSD 982.02 M2,020
Circulating tumor DNA is screened for early cancer detection.
2016Menlo Park, California, United StatesUSD 3.22 BUSD 147.17 M1,000
Nanopore-based electronic systems for single-molecule analysis are developed.
2005Oxford, Oxfordshire, United KingdomUSD 1.3 BUSD 301.49 M1,480
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits
2006Sunnyvale, California, United StatesUSD 943.53 MUSD 189.9 M265
Provider of DNA testing services to create a family tree and ancestor
2003Yehud, Central District, IsraelUSD 40 M––
Genetically modified cell lines are developed using AAV gene-editing platform.
2007Cambridge, Cambridgeshire, United KingdomUSD 46.29 M––
Gene therapies for rare diseases including retinal dystrophies are developed.
2013Philadelphia, Pennsylvania, United StatesUSD 82.8 MUSD 64.73 M822
Therapeutics for genetic diseases are developed through targeted interventions.
2015Palo Alto, California, United StatesUSD 434.2 MUSD 502.08 M730
Provider of an online genealogy platform offering a host of services
1996Lehi, Utah, United StatesUSD 146.2 M––
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about SABiosciences

SABiosciences was founded in 1998.

SABiosciences is headquartered in Frederick, United States. It is registered at Frederick, Maryland, United States.

Peer Schatz is the current CEO of SABiosciences.

SABiosciences designs, develops, manufactures, and commercializes disease- and pathway-focused real-time PCR-based assay panels, which are used in biomedical research, as well as in the development of drugs and diagnostics. It offers real-time PCR assay panels designed for analysis of DNA, RNA, epigenetic, and microRNA targets in biological pathways associated with specific diseases, such as cancer, diabetes, immune, and cardiovascular disorders, as well as with pathways, such as apoptosis, signal transduction, and toxicology. The companys products also include SureSilencing, which are RNA interference shRNA plasmids; ELISArray kits to monitor multiple cytokines and chemokines simultaneously; EpiTect ChIP qPCR System, which provides a platform for the in vivo analysis of the interaction between DNA and nuclear proteins; EpiTect ChIP PCR array, which is a panel of primer assays for pathway or disease-focused genes; EpiTect Methyl II PCR system, a technology enabling the detection of CpG island DNA methylation of individual genes, as well as diseases or pathways focused gene panels without bisulfite modification; and PCR reagent kits, PCR array data analysis software, PCR array data analysis quick reference cards, and instrument setup instructions. In addition, the company provides services for genomic and expression analysis. SABiosciences Corporation was formerly known as SuperArray Bioscience Corporation and changed its name to SABiosciences Corporation in July 2008. The company was founded in 1998 and is based in Frederick, Maryland. As of December 14, 2009, SABiosciences Corporation operates as a subsidiary of Qiagen NV.

SABiosciences's top competitors include Abcam, Sino Biological and Meridian Bioscience.

SABiosciences offers QIAcuityDx, QIAwave Kits, Proteinase K, and TissueLyser III.

SABiosciences has 1 investor. Key investors include Qiagen.

Yes. SABiosciences was acquired by Qiagen in November 2009.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available